Arcus Biosciences (RCUS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

RCUS is expected to report earnings to -101 cents per share on November 05

Arcus Biosciences RCUS Stock Earnings Reports

Q3'24

Est.

$-1.02

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.95

Q4'23

Missed

by $0.06

Q3'23

Beat

by $0.19

The last earnings report on August 08 showed earnings per share of -101 cents, beating the estimate of -111 cents. With 345.14K shares outstanding, the current market capitalization sits at 1.41B.

View a ticker or compare two or three

Compare

RCUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RCUS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RCUS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3928 Point Eden Way

Phone

+1 510 694-6200

Employees

577

Web

https://www.arcusbio.com